Respiratory Distress Syndrome, Adult

Search with Google Search with Bing
Information
Disease name
Respiratory Distress Syndrome, Adult
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03111212 Completed Phase 3 Iloprost in Acute Respiratory Distress Syndrome June 25, 2019 August 14, 2021
NCT00004494 Completed Phase 1 Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis September 1998
NCT00029328 Completed Phase 1/Phase 2 Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation September 2001 September 2003
NCT00036062 Completed Phase 1/Phase 2 A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury August 2001 December 2002
NCT00094406 Completed Phase 1 Carbon Monoxide to Prevent Lung Inflammation October 13, 2004 March 11, 2010
NCT06430619 Completed Can Novel Oxygenation Indices Guide the Diagnosis of Acute Respiratory Distress Syndrome June 1, 2012 May 1, 2024
NCT00113685 Completed N/A Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury April 2003 March 2007
NCT00141726 Completed Phase 2 Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant October 2003 February 2009
NCT00157144 Completed Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005 October 2004 August 2006
NCT00201409 Completed Phase 2 A Randomized Trial of GM-CSF in Patients With ALI/ARDS July 2004 June 2009
NCT00217880 Completed N/A Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease July 2004 June 2009
NCT06199141 Completed Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO) January 1, 2017 December 31, 2023
NCT00236262 Completed N/A Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome October 2005 September 2006
NCT00267241 Completed N/A Effects of Different Assisted Mechanical Ventilation in Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS) Patients December 2005 November 2014
NCT00300248 Completed Long-Term Results in Mechanically Ventilated Individuals With Acute Lung Injury/Acute Respiratory Distress Syndrome October 2004 October 2012
NCT06159465 Completed Utility of Defining ARDS and Past and Current Definitions of ARDS December 13, 2023 April 15, 2024
NCT03188770 Completed Practice of Ventilation in Middle-Income Countries November 1, 2017 January 29, 2019
NCT02961166 Completed Immunglobulin M Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients January 2012 May 2016
NCT00351533 Completed Phase 2 A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI) July 2006 August 2009
NCT05210881 Completed Weaning From Nasal High Flow Therapy January 1, 2019 August 31, 2021
NCT00399581 Completed Phase 2 Comparison of Two Methods of High Frequency Oscillatory Ventilation in Individuals With Acute Respiratory Distress Syndrome November 2006 June 2009
NCT00416260 Completed Phase 1/Phase 2 Combined High Frequency Oscillation and Tracheal Gas Insufflation for Severe Acute Respiratory Distress Syndrome July 2006 September 2007
NCT05083130 Completed N/A Awake Prone Positioning in Moderate to Severe COVID-19 March 8, 2022 May 1, 2023
NCT00431158 Completed N/A ARDSnet Protocol vs. Open Lung Approach in ARDS January 2007 March 2013
NCT00455767 Completed Phase 2 Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients July 2006 September 2007
NCT00458926 Completed Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care November 2003 December 2009
NCT04744090 Completed Phase 2 Roflumilast as add-on Therapy in Early Cases of ARDS March 21, 2021 January 1, 2022
NCT04710329 Completed High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients January 16, 2021 February 10, 2021
NCT00548795 Completed Viral-Related Neutrophil Response and Condition Severity in People With ARDS August 2007 July 2012
NCT00605527 Completed Understanding the Role of Genes and Biomarkers in the Inflammation and Blood Clotting Process in Children With Acute Lung Injury November 2007 December 2016
NCT00605696 Completed Phase 2 Early Insulin and Development of ARDS April 2008 September 2013
NCT04582201 Completed Phase 1/Phase 2 Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2 September 21, 2020 April 23, 2023
NCT00000579 Completed Phase 3 Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) September 1994 July 2004
NCT00719446 Completed Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials October 2007 October 2014
NCT00883948 Completed Phase 3 Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study) December 2007 May 2011
NCT04510662 Completed Phase 2 Telmisartan in Respiratory Failure Due to COVID-19 August 12, 2020 May 25, 2021
NCT04388826 Completed Phase 2 COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 June 18, 2020 August 13, 2021
NCT01119872 Completed N/A Pilot Study of Positive-End Expiratory Pressure in Acute Respiratory Distress Syndrome January 2003 December 2008
NCT04378582 Completed Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU May 7, 2020 August 5, 2020
NCT01167621 Completed Changes in Refractory Acute Respiratory Distress Syndrome (ARDS) Patients Under High Frequency Oscillation-ventilation September 2010 September 2012
NCT01256333 Completed Optimization of Arterial Oxygen Transport by Positive End-expiratory Pressure Variation in Acute Respiratory Distress Syndrome January 2011
NCT01374022 Completed N/A ART - Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial June 2011 December 2017
NCT04345887 Completed Spironolactone in Covid-19 Induced ARDS May 5, 2020 July 5, 2020
NCT04297397 Completed Personalised Simulation Technologies for Optimising Treatment in the Intensive Care Unit February 20, 2020 May 31, 2022
NCT01468142 Completed Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure February 2012 December 2016
NCT01601223 Completed Local Assessment of Ventilatory Management During General Anesthesia for Surgery January 2013 November 2013
NCT04157946 Completed The Role of Morphological Phenotype in ARDS August 7, 2017 July 20, 2019
NCT01743105 Completed N/A Reproductibility of TM-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the ER August 2013 January 2014
NCT03969914 Completed PEEP-induced Changed in RRI as Physiological Background of Ventilator-induced Kidney Injury May 1, 2019 June 15, 2020
NCT03818854 Completed Phase 2 Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome November 26, 2019 September 30, 2023
NCT02097641 Completed Phase 2 Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) March 15, 2014 February 9, 2018
NCT03807804 Completed Phase 2 Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome January 1, 2019 December 14, 2021
NCT03712215 Completed N/A STUDY OF ELECTRICAL STIMULATION IN PULMONARY FUNCTION IN INTENSIVE CARE UNIT September 4, 2018 January 31, 2019
NCT02273687 Completed N/A Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department October 29, 2014 September 29, 2017
NCT03539783 Completed Identifying PARDS Endotypes April 1, 2018 September 5, 2022
NCT03337373 Completed Phase 4 The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium December 15, 2017 August 31, 2018
NCT02439151 Completed N/A New Lung Ventilation Strategies Guided by Transpulmonary Pressure in VV-ECMO for Severe ARDS May 1, 2015 June 25, 2020
NCT03202394 Completed Phase 2 Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS August 5, 2017 June 15, 2020
NCT02664090 Completed Hemodynamic Assessment With Trans-esophageal Doppler (TED) During Prone Ventilation in ARDS Patients January 20, 2016 January 18, 2017
NCT02732041 Completed Asynchrony During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome May 25, 2016 February 2019
NCT02759770 Completed Risk Factors and Prediction Score of ARDS After Cardiac Surgery July 1, 2017 September 30, 2017
NCT02799940 Completed Abnormalities in Lung Computed Tomography and Physiological Alterations in Patients With Acute Respiratory Distress Syndrome August 2016 May 19, 2019
NCT05604430 Enrolling by invitation Pre-hospital Ventilation Clinical Study June 30, 2022 June 30, 2024
NCT05081895 Enrolling by invitation Ventilation and Perfusion in the Respiratory System August 19, 2021 July 2024
NCT04545424 Recruiting Phase 2 Trial of Therapeutic Hypothermia in Patients With ARDS June 29, 2021 September 30, 2025
NCT03368092 Recruiting Phase 3 Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma March 4, 2019 December 1, 2024
NCT03709199 Recruiting Long Term Follow up of Children Enrolled in the REDvent Study October 1, 2018 May 1, 2026
NCT04012073 Recruiting Phase 3 Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome November 1, 2022 April 30, 2025
NCT04139733 Recruiting Early Use of Prone Position in ECMO for Severe ARDS November 1, 2019 October 30, 2024
NCT04228471 Recruiting N/A Early PReserved SPONtaneous Breathing Activity in Mechanically Ventilated Patients With ARDS (PReSPON) February 8, 2020 July 2024
NCT05715762 Recruiting Determine the Effects of Prone Positioning and NO in COVID-19 ARDS by EIT December 21, 2022 December 31, 2023
NCT06174636 Recruiting N/A Lung Overdistension and Abdominal Pressure Rise June 20, 2023 June 2025
NCT06203405 Recruiting N/A The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial December 22, 2023 June 30, 2025
NCT04382391 Terminated N/A Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms May 15, 2020 April 13, 2023
NCT04028336 Terminated N/A The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients? December 20, 2019 January 7, 2021
NCT04395105 Terminated Phase 3 Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial May 21, 2020 May 21, 2021
NCT02622724 Terminated Phase 3 Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS) December 23, 2015 May 23, 2018
NCT00944437 Terminated N/A Continuous Positive Airway Pressure (CPAP) Ventilation Using a Novel Full-Face Mask Versus Conventional Helmet May 2008 July 2010
NCT02370095 Terminated Phase 2 Treprostinil Sodium Inhalation for Patients At High Risk for ARDS February 2015 November 7, 2017
NCT02252094 Terminated N/A Ultra-protective Pulmonary Ventilation Supported by Low Flow ECCO2R for Severe ARDS May 22, 2017 May 31, 2019
NCT00682500 Terminated Phase 3 Calfactant for Direct Acute Respiratory Distress Syndrome May 2008 February 2011
NCT00609180 Terminated Phase 3 Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study) December 2007 April 2009
NCT00112164 Terminated Phase 2 Activated Protein C to Treat Acute Lung Injuries January 2005 February 2007
NCT01461889 Terminated Phase 3 INR-Triggered Transfusion In GI Bleeders From ER July 2011 August 2015
NCT04778059 Terminated Phase 2 Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 July 27, 2021 May 10, 2022
NCT00434993 Terminated Phase 2/Phase 3 Drug Study of Albuterol to Treat Acute Lung Injury August 2007 November 2008
NCT00357929 Terminated N/A Weaning From Mechanical Ventilation Using Permissive Hypercarbia August 2006 June 14, 2007
NCT02895373 Terminated Phase 2 PGE1 as Additive Anticoagulant in ECMO-Therapy July 2016 July 2021
NCT04347980 Terminated Phase 3 Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 April 17, 2020 August 7, 2020
NCT00233207 Terminated Phase 2 IC14 Antibodies to Treat Individuals With Acute Lung Injury September 2005 June 2007
NCT03424798 Unknown status Measuring Heart and Lung Function in Critical Care October 21, 2017 September 2020
NCT03788096 Unknown status N/A Peer Support for Post Intensive Care Syndrome Self-Management April 20, 2020 January 27, 2021
NCT02112500 Unknown status Phase 2 Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure February 2014 December 2016
NCT01992237 Unknown status Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients October 2013 June 2018
NCT01990456 Unknown status N/A Strategies for Optimal Lung Ventilation in ECMO for ARDS: The SOLVE ARDS Study September 2014
NCT03971331 Unknown status N/A The Value of Combined Critical Care Ultrasound and PAC Monitor Oriented Therapy Protocol to Patients of ARDS With ACP July 1, 2019 December 30, 2021
NCT01716962 Unknown status Effects of Positive End-expiratory Pressure and Tidal Volume on Fluid Responsiveness of Acute Respiratory Distress Syndrome November 2012
NCT01391481 Unknown status Phase 2 Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome August 2011 April 2015
NCT01165528 Unknown status N/A Adaptive Support Ventilation in Acute Respiratory Distress Syndrome (ARDS) January 2010
NCT01070654 Unknown status N/A Inflammatory Effects of a Lung Recruitment Manoeuvre June 2010 December 2010
NCT04516486 Unknown status Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients March 9, 2020 December 31, 2020
NCT04520815 Unknown status Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory Distress June 24, 2020 June 30, 2022
NCT00542737 Unknown status N/A Evaluating a Web-Based Ventilator Management Educational Program for Clinicians (The Lung Injury Knowledge Network [LINK] Study) February 2009 July 2014
NCT00465374 Unknown status Phase 3 A Validation/Interventional Study on Stress Index in Predicting Mechanical Stress in ARDS Patients October 2002
NCT00429637 Unknown status Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients December 2004 January 2009
NCT02892799 Unknown status N/A Non-invasive Fluid Management November 12, 2015 December 2020
NCT03236272 Unknown status Establishment of a Biomarkers-based Early Warning System of Acute Respiratory Distress Syndrome (ARDS) September 15, 2017 December 31, 2020
NCT02342756 Unknown status N/A Esophageal Pressure-Guided Optimal PEEP/mPaw in CMV and HFOV: The EPOCH Study January 2015 December 2017
NCT00308022 Withdrawn Phase 2/Phase 3 Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation January 2006 December 31, 2009
NCT00319631 Withdrawn Role of Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury/Adult Respiratory Distress Syndrome (ARDS) January 2006 January 2017
NCT04508933 Withdrawn Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients September 1, 2020 December 31, 2020
NCT03376854 Withdrawn Phase 2 Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS May 1, 2018 April 27, 2021
MeSH unique ID (MeSH (Medical Subject Headings))
D012128